MIST Earnings Milestone Pharmaceuticals Inc.
Reported EPS, revenue and net income by fiscal period (SEC EDGAR) — quarterly and annual. Full financials → Chart & overview → Updated
Annual results
EPS
Net income
ROE
Quarterly results
EPS
Revenue
Net income
Reported EPS history
1–24 of 24
| Q2 2026 | 2026-06-30 | -0.41 | 2026-08-12 | 10-Q |
| Q1 2026 | 2026-03-31 | -0.20 | 2026-05-13 | 10-Q |
| FY 2025 | 2025-12-31 | -0.75 | 2026-03-20 | 10-K |
| Q3 2025 | 2025-09-30 | -0.60 | 2025-11-12 | 10-Q |
| Q2 2026 | 2025-06-30 | -0.51 | 2026-08-12 | 10-Q |
| Q1 2026 | 2025-03-31 | -0.31 | 2026-05-13 | 10-Q |
| FY 2025 | 2024-12-31 | -0.67 | 2026-03-20 | 10-K |
| Q3 2025 | 2024-09-30 | -0.48 | 2025-11-12 | 10-Q |
| Q2 2025 | 2024-06-30 | -0.34 | 2025-08-12 | 10-Q |
| Q1 2025 | 2024-03-31 | -0.21 | 2025-05-14 | 10-Q |
| FY 2024 | 2023-12-31 | -1.39 | 2025-03-13 | 10-K |
| Q3 2024 | 2023-09-30 | -1.07 | 2024-11-12 | 10-Q |
| Q2 2024 | 2023-06-30 | -0.72 | 2024-08-08 | 10-Q |
| Q1 2024 | 2023-03-31 | -0.35 | 2024-05-13 | 10-Q |
| FY 2023 | 2022-12-31 | -1.38 | 2024-03-21 | 10-K |
| Q3 2023 | 2022-09-30 | -1.07 | 2023-11-13 | 10-Q |
| Q2 2023 | 2022-06-30 | -0.73 | 2023-08-10 | 10-Q |
| Q1 2023 | 2022-03-31 | -0.33 | 2023-05-11 | 10-Q |
| FY 2021 | 2021-12-31 | -1.02 | 2022-03-24 | 10-K |
| Q3 2022 | 2021-09-30 | -0.62 | 2022-11-10 | 10-Q |
| Q2 2022 | 2021-06-30 | -0.28 | 2022-08-10 | 10-Q |
| Q1 2022 | 2021-03-31 | -0.30 | 2022-05-12 | 10-Q |
| FY 2021 | 2020-12-31 | -1.70 | 2022-03-24 | 10-K |
| Q2 2021 | 2020-06-30 | -1.20 | 2021-08-11 | 10-Q |
Source: SEC EDGAR / XBRL (reported actuals; no consensus estimates). Some issuers (e.g. mortgage REITs, banks) don't report a conventional revenue line, so those charts may be omitted. Informational only — not financial advice.